SCHEMBL9129019

SCHEMBL9129019

O=S(=O)(O)CCCNC(Cc1ccccc1)c1ccccc1.[NaH]

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
HTT P42858 2/20 0.48
NCOA1 Q15788 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NCOA3 Q9Y6Q9 1/20 0.48
CCR3 P51677 1/20 0.46
ADRB3 P13945 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SIGMAR1 Q99720 3/20 0.40
SCN9A Q15858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9848968 0.99 ALDH1A1 (0.49) ALDH1A1HTTNCOA1SMN1; SMN2NCOA3
SCHEMBL9129025 0.83 ALDH1A1 (0.45) ALDH1A1HTTNCOA1SMN1; SMN2NCOA3
SCHEMBL353339 0.82 EPHX2 (0.44) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL353673 0.82 EPHX2 (0.44) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL9127621 0.80 MTOR (0.55) ALDH1A1ADRB3MAPTCYP3A4
SCHEMBL10231532 0.79 CNR1 (0.52) MAPTKDM4ECYP3A4SIGMAR1
SCHEMBL10231525 0.79 CNR1 (0.52) MAPTKDM4ECYP3A4SIGMAR1
SCHEMBL12905042 0.79 CNR1 (0.52) MAPTKDM4ECYP3A4SIGMAR1
SCHEMBL916682 0.79 SIGMAR1 (0.65) CYP1A2CYP2D6CYP2C19SIGMAR1
SCHEMBL9848956 0.79 MTOR (0.57) ALDH1A1ADRB3MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5422355-A Also for treating memory impairment, dementia or cerebral insufficiency JOHN WYETH & BROTHER, LIMITED (GB) 1995-06-06 US disclosed
US-5260331-A Selective gamma aminobutyric acid autoreceptors; treatment of dementia JOHN WYETH & BROTHER LIMITED (GB) 1993-11-09 US disclosed
US-5086073-A Brain disorders JOHN WYETH & BROTHER LIMITED (GB) 1992-02-04 US disclosed
EP-0407032-A2 Aromatic and heteroaromatic amines for treating depressions, cerebral insufficiency disorders or dementia JOHN WYETH & BROTHER LIMITED (GB) 1991-01-09 EP disclosed